Quick Takeaways
- Richard Jacinto II filed SCHEDULE 13G/A for DiaMedica Therapeutics Inc. Voting Common Shares, no par value (DMAC).
- Disclosed ownership: 9.6%.
- Date of event: 30 Sep 2025.
Richard Jacinto II - 30 Sep 2025 SCHEDULE 13G/A Report for DiaMedica Therapeutics Inc. Voting Common Shares, no par value (DMAC)
- Filing Manager
- Richard Jacinto II
- Reporting Manager
- Richard Jacinto II
- Symbol
- DMAC
- Shares outstanding
- 51,654,406 shares
- Disclosed Ownership
- 4,958,823 shares
- Ownership
- 9.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 07 Nov 2025, 17:30:12 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Richard Jacinto II disclosed 9.6% ownership in DiaMedica Therapeutics Inc. Voting Common Shares, no par value (DMAC) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 Nov 2025, 17:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Richard Jacinto II | 9.6% | 4,958,823 | 4,958,823 | 0 | /s/ Richard Jacinto II | Richard Jacinto II |